Amphiregulin

Last updated
AREG
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases AREG , AR, AREGB, CRDGF, SDGF, amphiregulin
External IDs OMIM: 104640 MGI: 88068 HomoloGene: 1252 GeneCards: AREG
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001657

NM_009704

RefSeq (protein)

NP_001648

NP_033834

Location (UCSC) Chr 4: 74.45 – 74.46 Mb Chr 5: 91.29 – 91.3 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Amphiregulin, also known as AREG, is a protein synthesized as a transmembrane glycoprotein with 252 aminoacids and it is encoded by the AREG gene. [5] [6] [7] in humans. [8]

Contents

Function

The protein encoded by this gene is a member of the epidermal growth factor (EGF) family. [5]

It is a critical autocrine growth factor as well as a mitogen for astrocytes, Schwann cells, and fibroblasts. It is ligand for epidermal growth factor (EGF) and it is related to transforming growth factor alpha (TGF-alpha). This protein interacts with the Epidermal growth factor receptor (EGFR) to promote the growth of normal epithelial cells.

Biological role

AREG is a critical factor in estrogen action and ductal development of the mammary glands. [9] [10] [11] [12] [13] Amphiregulin has been found to be essential for mammary ductal development, as evidenced by absence of ductal growth in amphiregulin knockout mice. [12] This is similar to the phenotypes of EGFR and ERα knockout mice, which also show absence of ductal growth. [12] Amphiregulin is expressed in many parts of body such as ovaries, placenta, pancreas, breasts, lungs and spleen. Expression of amphiregulin can be induced by TGF-α, TNF-α, interleukin 1, and prostaglandins. [14] [15]

Clinical significance

Role in tissue repair

Generally, amphiregulin is considered to be a part of type 2 mediated resistance and tolerance, the latter of which occurs by promoting the reestablishment of tissue integrity after damage that is due to acute or chronic inflammation. Its involvement in tissue repair can be explained by its dual role, as amphiregulin can induce mitogenic signals, but it can also lead to cell differentiation of epithelial cells. [16]

While epithelial-derived amphiregulin can promote tissue repair, several immune cells are found to express it in cases of tissue damage, so amphiregulin is part of the crosstalk between immune and epithelial cells. [16] [17]

A population of immune cells that is found to increase its amphiregulin expression after tissue damage, is the innate lymphoid cell 2 (ILC2) population. This has been observed in several organs, such as the lung, the intestine, and the skin. The expression of amphiregulin by ILC2s can be induced by interleukin 33 (IL-33). [18] Also, in skin derived ILC2s, amphiregulin expression was regulated by the interaction of killer-cell lectin-like receptor G1 (KLRG1) with E-cadherin. [19] After intestinal damage, activated intestinal ILC2s produce amphiregulin which enhances the production of mucin by epithelial cells, increases the expression of Claudin-1 and promotes the activity of goblet cells. These functions of amphiregulin lead to increased junction strength, as well as the strengthening of the mucus layer. [18]

Tissue resident regulatory T cells (Tregs) can also express amphiregulin to promote tissue repair. In the skeletal muscle, the IL-33 receptor (ST2) expressing Tregs have a distinct T-cell receptor (TCR) repertoire, [20] and TCR signals don’t seem to be required for amphiregulin production, but this process can be dependent on the IL-33/ST2 (or IL-33 receptor) pathway and the expression of interleukin 18 receptor (IL-18R) on tissue resident Tregs. [21] Also, amphiregulin that is expressed from these Tregs can further enhance their function, forming an autocrine positive feedback loop. [22] Amphiregulin-expressing tissue resident Tregs have been observed in the lung, where most of them are CD44 hi CD62L lo and they express higher levels of CD103, programmed cell death protein 1 (PD-1), glucocorticoid-induced TNFR-related protein (GITR), cytotoxic T-lymphocyte antigen 4 (CTLA-4) and KLRG1. [21] They have been found in injured muscles, where this population has been associated with eosinophil influx, and the production of amphiregulin could enhance the colony-forming efficiency and myogenic differentiation of skeletal muscle satellite cells in vitro, increasing muscle healing. [16] In the inflamed colon, Gata3 +Helios+ Tregs express high levels of amphiregulin too. [23] Moreover, Tregs that express amphiregulin, along with keratinocyte growth factor (KGF), CD39 and CD73, act on parenchymal cells to promote tissue repair and regeneration. [21]

Some unconventional T cells have been associated with the promotion of tissue repair by amphiregulin in a direct or in an indirect manner. After intestinal damage, mucosal-associated invariant T (MAIT) cells produce amphiregulin that leads to epithelial cell turnover and enhances the activity of goblet cells. Also, a pro-repair response by amphiregulin produced by ILC2s and Tregs, that is dependent on IL-33 signaling, is induced by gamma delta (γδ) T cells that produce interleukin 17A (IL-17A). This correlation between IL-17A-producing γδ T cells and amphiregulin has been observed in the lungs and in the oral mucosa. [18]

Psoriasis

Mutations in this encoded protein are associated with a psoriasis-like skin phenotype. [24] [5] Higher circulating levels of amphiregulin are associated with AGVHD progression. [25] [26] [27]

Cancer

Overexpression of amphiregulin is connected with cancer of the breast, prostate, colon, pancreas, lung, spleen, and bladder. [28] [29] [12]

Rheumatoid arthritis

It seems that expression of AREG is connected with proliferation of fibroblasts and production of proinflammatory cytokines interleukin 8 and vascular endothelial growth factor (VEGF). [30]

Fibrosis

Chronic elevation of amphiregulin levels has been associated with fibrosis in several organs. ILC2s are drivers of liver, skin, and pulmonary fibrosis, and their expression of interleukin 13 (IL-13) and amphiregulin is implicated in this process. [16] Pathogenic memory Th2 cells that express amphiregulin are also involved in pulmonary fibrosis. Exposure to house dust mite leads to the increase of amphiregulin-expressing pathogenic memory Th2 cells. This increase might be related to the IL-33/ST2 signaling, as blocking this pathway causes less production of amphiregulin. The function of amphiregulin in airway fibrosis is related to eosinophils that express EGFR, in which amphiregulin binds to, resulting in the upregulation of inflammatory genes, including Spp1 that encodes osteopontin. The expression of osteopontin by eosinophils shapes the pathogenesis of pulmonary fibrosis. [31] Moreover, macrophage-derived amphiregulin is involved in the transforming growth factor beta (TGF-β)-induced fibrosis too, as it has been found to activate latent TGF-β through the activation of integrin-αV complex. [16] [32] [33] In the liver, ongoing necrosis leads to the activation of hepatic ILC2s which release amphiregulin along with IL-13. The release of them activates the hepatic stellate cells that transform into myofibroblasts, and ultimately promotes liver fibrosis. [19]

Inflammation

Amphiregulin is part of cellular response type 2. [34] It was found that the cell source of amphiregulin is innate lymphoid cells 2 (ILC2) which are dependent on interleukin 33. ILC2 expressed amphiregulin after tissue damage of the intestines and activation by IL-33. Moreover, endogenous AREG with IL-33 decreased the intestinal inflammation in mice with normal count of T-lymphocytes and in deficient mice. [35]

Related Research Articles

<span class="mw-page-title-main">Mammary gland</span> Exocrine gland in humans and other mammals

A mammary gland is an exocrine gland in humans and other mammals that produces milk to feed young offspring. Mammals get their name from the Latin word mamma, "breast". The mammary glands are arranged in organs such as the breasts in primates, the udder in ruminants, and the dugs of other animals. Lactorrhea, the occasional production of milk by the glands, can occur in any mammal, but in most mammals, lactation, the production of enough milk for nursing, occurs only in phenotypic females who have gestated in recent months or years. It is directed by hormonal guidance from sex steroids. In a few mammalian species, male lactation can occur. With humans, male lactation can occur only under specific circumstances.

Autocrine signaling is a form of cell signaling in which a cell secretes a hormone or chemical messenger that binds to autocrine receptors on that same cell, leading to changes in the cell. This can be contrasted with paracrine signaling, intracrine signaling, or classical endocrine signaling.

The regulatory T cells (Tregs or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Treg cells express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4+ cells. Because effector T cells also express CD4 and CD25, Treg cells are very difficult to effectively discern from effector CD4+, making them difficult to study. Research has found that the cytokine transforming growth factor beta (TGF-β) is essential for Treg cells to differentiate from naïve CD4+ cells and is important in maintaining Treg cell homeostasis.

<span class="mw-page-title-main">Epidermal growth factor receptor</span> Transmembrane protein

The epidermal growth factor receptor is a transmembrane protein that is a receptor for members of the epidermal growth factor family of extracellular protein ligands.

<span class="mw-page-title-main">Interleukin 4</span> Mammalian protein found in Mus musculus

The interleukin 4 is a cytokine that induces differentiation of naive helper T cells (Th0 cells) to Th2 cells. Upon activation by IL-4, Th2 cells subsequently produce additional IL-4 in a positive feedback loop. IL-4 is produced primarily by mast cells, Th2 cells, eosinophils and basophils. It is closely related and has functions similar to IL-13.

<span class="mw-page-title-main">Interleukin 13</span> Protein and coding gene in humans

Interleukin 13 (IL-13) is a protein that in humans is encoded by the IL13 gene. IL-13 was first cloned in 1993 and is located on chromosome 5q31.1 with a length of 1.4kb. It has a mass of 13 kDa and folds into 4 alpha helical bundles. The secondary structural features of IL-13 are similar to that of Interleukin 4 (IL-4); however it only has 25% sequence identity to IL-4 and is capable of IL-4 independent signaling. IL-13 is a cytokine secreted by T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells, basophils, eosinophils and nuocytes. Interleukin-13 is a central regulator in IgE synthesis, goblet cell hyperplasia, mucus hypersecretion, airway hyperresponsiveness, fibrosis and chitinase up-regulation. It is a mediator of allergic inflammation and different diseases including asthma.

<span class="mw-page-title-main">Myofibroblast</span>

A myofibroblast is a cell phenotype that was first described as being in a state between a fibroblast and a smooth muscle cell.

<span class="mw-page-title-main">Interleukin 11</span> Protein-coding gene in the species Homo sapiens

Interleukin 11 is a protein that in humans is encoded by the IL11 gene.

<span class="mw-page-title-main">Hepatocyte growth factor</span> Mammalian protein found in Homo sapiens

Hepatocyte growth factor (HGF) or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

<span class="mw-page-title-main">Heparin-binding EGF-like growth factor</span> Protein-coding gene in the species Homo sapiens

Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of proteins that in humans is encoded by the HBEGF gene.

<span class="mw-page-title-main">Epiregulin</span> Protein found in humans

Epiregulin (EPR) is a protein that in humans is encoded by the EREG gene.

Interleukin 35 (IL-35) is a recently discovered anti-inflammatory cytokine from the IL-12 family. Member of IL-12 family - IL-35 is produced by wide range of regulatory lymphocytes and plays a role in immune suppression. IL-35 can block the development of Th1 and Th17 cells by limiting early T cell proliferation.

<span class="mw-page-title-main">Teratocarcinoma-derived growth factor 1</span> Protein-coding gene in the species Homo sapiens

Teratocarcinoma-derived growth factor 1 is a protein that in humans is encoded by the TDGF1 gene. The protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants.

<span class="mw-page-title-main">IL2RA</span> Mammalian protein found in Homo sapiens

The Interleukin-2 receptor alpha chain is a protein involved in the assembly of the high-affinity Interleukin-2 receptor, consisting of alpha (IL2RA), beta (IL2RB) and the common gamma chain (IL2RG). As the name indicates, this receptor interacts with Interleukin-2, a pleiotropic cytokine which plays an important role in immune homeostasis.

Breast development, also known as mammogenesis, is a complex biological process in primates that takes place throughout a female's life.

<span class="mw-page-title-main">IL1RL1</span> Protein-coding gene in humans

Interleukin 1 receptor-like 1, also known as IL1RL1 and ST2, is a protein that in humans is encoded by the IL1RL1 gene.

Innate lymphoid cells (ILCs) are the most recently discovered family of innate immune cells, derived from common lymphoid progenitors (CLPs). In response to pathogenic tissue damage, ILCs contribute to immunity via the secretion of signalling molecules, and the regulation of both innate and adaptive immune cells. ILCs are primarily tissue resident cells, found in both lymphoid, and non- lymphoid tissues, and rarely in the blood. They are particularly abundant at mucosal surfaces, playing a key role in mucosal immunity and homeostasis. Characteristics allowing their differentiation from other immune cells include the regular lymphoid morphology, absence of rearranged antigen receptors found on T cells and B cells, and phenotypic markers usually present on myeloid or dendritic cells.

Liver regeneration is the process by which the liver is able to replace damaged or lost liver tissue. The liver is the only visceral organ with the capacity to regenerate. The liver can regenerate after partial hepatectomy or injury due to hepatotoxic agents such as certain medications, toxins, or chemicals. Only 51% of the original liver mass is required for the organ to regenerate back to full size. The phenomenon of liver regeneration is seen in all vertebrates, from humans to fish. The liver manages to restore any lost mass and adjust its size to that of the organism, while at the same time providing full support for body homeostasis during the entire regenerative process. The process of regeneration in mammals is mainly compensatory growth or hyperplasia because while the lost mass of the liver is replaced, it does not regain its original shape. During compensatory hyperplasia, the remaining liver tissue becomes larger so that the organ can continue to function. In lower species such as fish, the liver can regain both its original size and mass.

<span class="mw-page-title-main">ILC2</span>

ILC2 cells, or type 2 innate lymphoid cells are a type of innate lymphoid cell. Not to be confused with the ILC. They are derived from common lymphoid progenitor and belong to the lymphoid lineage. These cells lack antigen specific B or T cell receptor because of the lack of recombination activating gene. ILC2s produce type 2 cytokines and are involved in responses to helminths, allergens, some viruses, such as influenza virus and cancer.

Th22 cells are subpopulation of CD4+ T cells that produce interleukin-22 (IL-22). They play a role in the protective mechanisms against variety of bacterial pathogens, tissue repair and wound healing, and also in pathologic processes, including inflammations, autoimmunity, tumors, and digestive organs damages.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000109321 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000029378 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "Entrez Gene: AREG amphiregulin (schwannoma-derived growth factor)".
  6. Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ (February 1989). "Structure and function of human amphiregulin: a member of the epidermal growth factor family". Science. 243 (4894 Pt 1): 1074–1076. Bibcode:1989Sci...243.1074S. doi:10.1126/science.2466334. PMID   2466334.
  7. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, et al. (May 1990). "The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity". Molecular and Cellular Biology. 10 (5): 1969–1981. doi:10.1128/MCB.10.5.1969. PMC   360543 . PMID   2325643.
  8. "AREG (amphiregulin (schwannoma-derived growth factor))". atlasgeneticsoncology.org. Archived from the original on 2019-08-27. Retrieved 2019-08-27.
  9. Aupperlee MD, Leipprandt JR, Bennett JM, Schwartz RC, Haslam SZ (May 2013). "Amphiregulin mediates progesterone-induced mammary ductal development during puberty". Breast Cancer Research. 15 (3): R44. doi: 10.1186/bcr3431 . PMC   3738150 . PMID   23705924.
  10. LaMarca HL, Rosen JM (2007). "Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage". Breast Cancer Research. 9 (4): 304. doi: 10.1186/bcr1740 . PMC   2206713 . PMID   17659070.
  11. Kariagina A, Xie J, Leipprandt JR, Haslam SZ (October 2010). "Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers". Hormones & Cancer. 1 (5): 229–244. doi:10.1007/s12672-010-0048-0. PMC   3000471 . PMID   21258428.
  12. 1 2 3 4 McBryan J, Howlin J, Napoletano S, Martin F (June 2008). "Amphiregulin: role in mammary gland development and breast cancer". Journal of Mammary Gland Biology and Neoplasia. 13 (2): 159–169. doi:10.1007/s10911-008-9075-7. PMID   18398673. S2CID   13229645.
  13. Sternlicht MD, Sunnarborg SW (June 2008). "The ADAM17-amphiregulin-EGFR axis in mammary development and cancer". Journal of Mammary Gland Biology and Neoplasia. 13 (2): 181–194. doi:10.1007/s10911-008-9084-6. PMC   2723838 . PMID   18470483.
  14. "AREG (amphiregulin (schwannoma-derived growth factor))". atlasgeneticsoncology.org. Archived from the original on 2019-08-27. Retrieved 2019-08-27.
  15. Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A (December 2011). "The multiple roles of amphiregulin in human cancer". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1816 (2): 119–131. doi:10.1016/j.bbcan.2011.05.003. PMID   21658434.
  16. 1 2 3 4 5 Zaiss DM, Gause WC, Osborne LC, Artis D (February 2015). "Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair". Immunity. 42 (2): 216–226. doi:10.1016/j.immuni.2015.01.020. PMC   4792035 . PMID   25692699.
  17. Singh SS, Chauhan SB, Kumar A, Kumar S, Engwerda CR, Sundar S, et al. (February 2022). "Amphiregulin in cellular physiology, health, and disease: Potential use as a biomarker and therapeutic target". Journal of Cellular Physiology. 237 (2): 1143–1156. doi:10.1002/jcp.30615. PMID   34698381. S2CID   239889516.
  18. 1 2 3 Cox JR, Cruickshank SM, Saunders AE (2021). "Maintenance of Barrier Tissue Integrity by Unconventional Lymphocytes". Frontiers in Immunology. 12: 670471. doi: 10.3389/fimmu.2021.670471 . PMC   8079635 . PMID   33936115.
  19. 1 2 Ochel A, Tiegs G, Neumann K (April 2019). "Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives". International Journal of Molecular Sciences. 20 (8): 1896. doi: 10.3390/ijms20081896 . PMC   6514972 . PMID   30999584.
  20. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. (2013-12-05). "A special population of regulatory T cells potentiates muscle repair". Cell. 155 (6): 1282–1295. doi:10.1016/j.cell.2013.10.054. ISSN   1097-4172. PMC   3894749 . PMID   24315098.
  21. 1 2 3 Zhang C, Li L, Feng K, Fan D, Xue W, Lu J (2017-10-25). "'Repair' Treg Cells in Tissue Injury". Cellular Physiology and Biochemistry. 43 (6): 2155–2169. doi: 10.1159/000484295 . PMID   29069643.
  22. Boothby IC, Cohen JN, Rosenblum MD (May 2020). "Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair". Science Immunology. 5 (47). doi:10.1126/sciimmunol.aaz9631. PMC   7274208 . PMID   32358172.
  23. Ito M, Komai K, Nakamura T, Srirat T, Yoshimura A (May 2019). "Tissue regulatory T cells and neural repair". International Immunology. 31 (6): 361–369. doi: 10.1093/intimm/dxz031 . PMID   30893423.
  24. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, et al. (April 2005). "Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice". The American Journal of Pathology. 166 (4): 1009–1016. doi:10.1016/S0002-9440(10)62322-X. PMC   1780140 . PMID   15793282.
  25. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, et al. (April 2005). "Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice". The American Journal of Pathology. 166 (4): 1009–1016. doi:10.1016/S0002-9440(10)62322-X. PMC   1780140 . PMID   15793282.
  26. Holtan SG, DeFor TE, Panoskaltsis-Mortari A, Khera N, Levine JE, Flowers ME, et al. (August 2018). "Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802". Blood Advances. 2 (15): 1882–1888. doi:10.1182/bloodadvances.2018017343. PMC   6093743 . PMID   30087106.
  27. Piepkorn M (April 1996). "Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases". The American Journal of Dermatopathology. 18 (2): 165–171. doi:10.1097/00000372-199604000-00010. PMID   8739992.
  28. Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A (December 2011). "The multiple roles of amphiregulin in human cancer". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1816 (2): 119–131. doi:10.1016/j.bbcan.2011.05.003. PMID   21658434.
  29. "AREG (amphiregulin (schwannoma-derived growth factor))". atlasgeneticsoncology.org. Archived from the original on 2019-08-27. Retrieved 2019-08-27.
  30. Yamane S, Ishida S, Hanamoto Y, Kumagai K, Masuda R, Tanaka K, et al. (April 2008). "Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients". Journal of Inflammation. 5: 5. doi: 10.1186/1476-9255-5-5 . PMC   2396620 . PMID   18439312.
  31. Hirahara K, Aoki A, Morimoto Y, Kiuchi M, Okano M, Nakayama T (May 2019). "The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin". Seminars in Immunopathology. 41 (3): 339–348. doi:10.1007/s00281-019-00735-6. PMID   30968186. S2CID   106409455.
  32. Huang H, Yin K, Tang H (April 2020). "Macrophage amphiregulin-pericyte TGF-β axis: a novel mechanism of the immune system that contributes to wound repair". Acta Biochimica et Biophysica Sinica. 52 (4): 463–465. doi: 10.1093/abbs/gmaa001 . PMID   32147698.
  33. Zaiss DM, Minutti CM, Knipper JA (July 2019). "Immune- and non-immune-mediated roles of regulatory T-cells during wound healing". Immunology. 157 (3): 190–197. doi:10.1111/imm.13057. PMC   6600083 . PMID   30866049.
  34. Zaiss DM, Yang L, Shah PR, Kobie JJ, Urban JF, Mosmann TR (December 2006). "Amphiregulin, a TH2 cytokine enhancing resistance to nematodes". Science. 314 (5806): 1746. Bibcode:2006Sci...314.1746Z. doi:10.1126/science.1133715. PMID   17170297. S2CID   27808704.
  35. Monticelli LA, Osborne LC, Noti M, Tran SV, Zaiss DM, Artis D (August 2015). "IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions". Proceedings of the National Academy of Sciences of the United States of America. 112 (34): 10762–10767. Bibcode:2015PNAS..11210762M. doi: 10.1073/pnas.1509070112 . PMC   4553775 . PMID   26243875.

Further reading